Fortress Biotech Inc
FBIO
NASDAQ
Biotechnology
$2.93
USD
-0.05 (-1.68%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $96.00M
Volume 1.0M
Revenue
$67.45M
TTM
+16.7%
YoY
Gross Margin
67%
TTM
+1.4%
YoY
Net Income
$128.94M
TTM
+221.0%
YoY
Operating Cash Flow
$157.64M
TTM
+312.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 13.1 | 16.4 | 17.0 | 18.1 | 15.9 |
YoY Growth | +0.8% | +10.2% | +16.4% | +19.6% | +21.2% |
Cost of Revenue | 4.8 | 4.9 | 5.8 | 5.4 | 6.2 |
Gross Profit | 8.3 | 11.5 | 11.3 | 12.6 | 9.7 |
Selling, General & Administrative | 25.7 | 38.8 | 17.4 | 14.7 | 15.9 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 30.7 | 47.9 | 18.7 | 15.4 | 17.6 |
Operating Income | -22.3 | -36.5 | -7.4 | -2.8 | -7.9 |
EBITDA | -21.1 | -35.3 | -6.3 | -1.6 | -6.6 |
Other Income / Expense | -0.1 | 26.7 | 18.3 | -2.0 | 152.9 |
Total Other Income / Expense | -2.4 | 24.8 | 16.3 | -3.4 | 150.2 |
Income Before Income Taxes | -24.7 | -11.7 | 8.9 | -6.2 | 142.3 |
Income Taxes | 0.0 | 0.0 | 0.0 | -0.8 | 5.1 |
Net Income | -24.7 | -11.7 | 8.8 | -5.4 | 137.2 |
Consolidated Net Income / Loss | -24.7 | -11.7 | 8.8 | -5.4 | 137.2 |
Net Income Attributable to Common Shareholders | -12.7 | 13.4 | 3.7 | -6.2 | 108.4 |
Basic EPS | -$0.48 | $0.50 | $0.13 | -$0.20 | $3.44 |
Diluted EPS | -$0.48 | $0.45 | $0.11 | -$0.28 | $2.82 |
Basic Shares Outstanding | 26.5M | 26.9M | 27.2M | 31.0M | 31.5M |
Diluted Shares Outstanding | 26.5M | 29.8M | 33.1M | 22.2M | 38.4M |